Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (681-690 of 723) with videos related to

Pageof 73
Sort By:
Clinical Endocrinology|January 1, 1979
Sensitive radioimmunoassay for somatostatin using N-[125I]-Tyr-somatostatin as labelled antigenA Dupont, D H Coy, G Alvarado-Urbina, et al.
Gynecologic and Obstetric Investigation|January 1, 1993
Changes in the abundance of mRNA for type-I 3 beta-hydroxysteroid dehydrogenase/delta 5-->delta 4 isomerase in the human placenta and fetal membranes during pregnancy and laborS C Riley, N S Bassett, E T Berdusco, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase geneF Mébarki, R Sanchez, E Rhéaume, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Intraovarian actions of GnRHF Labrie, C Séguin, F A Lefebvre, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 11, 2008
Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parametersB Han, S Li, D Song, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Potent antagonism between estrogens and androgens on GCDFP-15 expression and cell growth in the ZR-75-1 human breast cancer cellsF Labrie, J Simard, R Poulin, et al.
Human Molecular Genetics|September 1, 1994
Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasiaR Sanchez, F Mébarki, E Rhéaume, et al.
International Journal of Obesity|September 1, 1991
Expression of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) in adipose tissueF Labrie, J Simard, V Luu-The, et al.
Human Mutation|January 1, 1995
Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French CanadiansM C Vohl, P Couture, S Moorjani, et al.
Human Reproduction (Oxford, England)|January 23, 2015
Placental STAT3 signaling is activated in women with polycystic ovary syndromeM Maliqueo, I Sundström Poromaa, E Vanky, et al.
Pageof 73

Showing results (681-690 of 723) with videos related to

Sort By:
Pageof 73
Clinical Endocrinology|January 1, 1979
Sensitive radioimmunoassay for somatostatin using N-[125I]-Tyr-somatostatin as labelled antigenA Dupont, D H Coy, G Alvarado-Urbina, et al.
Gynecologic and Obstetric Investigation|January 1, 1993
Changes in the abundance of mRNA for type-I 3 beta-hydroxysteroid dehydrogenase/delta 5-->delta 4 isomerase in the human placenta and fetal membranes during pregnancy and laborS C Riley, N S Bassett, E T Berdusco, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase geneF Mébarki, R Sanchez, E Rhéaume, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Intraovarian actions of GnRHF Labrie, C Séguin, F A Lefebvre, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 11, 2008
Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parametersB Han, S Li, D Song, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Potent antagonism between estrogens and androgens on GCDFP-15 expression and cell growth in the ZR-75-1 human breast cancer cellsF Labrie, J Simard, R Poulin, et al.
Human Molecular Genetics|September 1, 1994
Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasiaR Sanchez, F Mébarki, E Rhéaume, et al.
International Journal of Obesity|September 1, 1991
Expression of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) in adipose tissueF Labrie, J Simard, V Luu-The, et al.
Human Mutation|January 1, 1995
Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French CanadiansM C Vohl, P Couture, S Moorjani, et al.
Human Reproduction (Oxford, England)|January 23, 2015
Placental STAT3 signaling is activated in women with polycystic ovary syndromeM Maliqueo, I Sundström Poromaa, E Vanky, et al.
Pageof 73